Skip to content
About CombiGene
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Video presentations
May 15, 2023
COO Peter Ekolind present at Aktiedagen Göteborg (only in Swedish)
May 12, 2023
Status update from CombiGene’s CEO
March 14, 2023
CEO Jan Nilsson present at Stora Aktiedagen Stockholm (only in Swedish)
Show more
Interviews & Articles
26 May, 2023
Prominent role for CombiGene in newly established national ATMP collaboration
17 May, 2023
Article about CombiGene’s epilepsy project published in Gene Therapy
17 May, 2023
BioStock: Zyneyro’s CEO on the collaboration with CombiGene
Show More
Stories
46th Adipose Tissue Discussion Group held in Edinburgh on the 23rd and 24th March 2023
On February 1, CombiGene hosted a one-day conference within the GeneNova project
Highlights from Gene Therapy in Rare Diseases Europe
Show More
